BPI 2026 has ended. This guide stays up as the record of who was there. Next: BPI 2027, Sep 20–23, 2027 in Boston
GB
Genetix Biotherapeutics at BPI 2026
Sep 22–25, 2026 Boston, MA ~3k attendees Website
Genetix Biotherapeutics takes part in 4 sessions at BPI 2026 in Boston. Its sessions centre on planning cell and gene therapy manufacturing. One asks how to design facilities when the patient count keeps moving, and another argues for phase-appropriate manufacturing designed with the end in mind.
| Organization | BPI 2026 Attendance |
|---|---|
GB Genetix Biotherapeutics Somerville, Massachusetts | |
Gene therapy company, formerly bluebird bio, with marketed lentiviral gene therapies for sickle cell disease, beta-thalassemia and cerebral adrenoleukodystrophy. | Chair Thu Sep 24 9:20am–9:30am Talk Thu Sep 24 11:45am–12:30pm Talk Thu Sep 24 4:30pm–5:30pm Talk Fri Sep 25 12:40pm–1:20pm |
Find decision makers at Genetix Biotherapeutics
Tell us what you sell and we’ll find the people at Genetix Biotherapeutics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the BioProcess International Conference & Exhibition or its organizers. Submit a correction